Skip to main content
. 2022 Jan 15;3:100019. doi: 10.1016/j.crviro.2022.100019

figs5.

figs5

TCID50 data of POS treated nasal HAEEC infected with SARS-CoV-2. Viral titer (TCID50/ml) readout of the samples shown in Fig. 5B. Panel A) shows post-exposure treatment with 10 μM Remdesivir, and 5 and 20 μM POS. Panel B) depicts pre-exposure treatment with 5 and 20 μM POS. Data represent the mean±SEM of two independent replicates. Not determined (nd) indicates virus titers below 2.4 log10 TCID50/ml in the two replicates, and (1/2) indicates virus titers below 2.4 log10 TCID50/ml in one replicate.